Plasma apolipoprotein H levels are different between aspirin induced respiratory diseases and aspirin tolerant asthma

Pulmonary Pharmacology and Therapeutics

Volumn 27, Issue 2, 2014, Pages 184-189

  Kim, Hee Jeong ^a   Park, Jong Sook ^a   Heo, Jeong Seok ^a   Moon, Kuk Young ^a   Park, Choon Sik ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Acetylsalicylic acid; Apolipoprotein H; Asthma; Blood plasma; Two dimensional gel electrophoresis

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA FIBRINOGEN PRECURSOR; BETA2 GLYCOPROTEIN 1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; FIBRIN BETA; HEAT SHOCK PROTEIN 90; KININOGEN 1 ISOFORM 2; PROAPOLIPOPROTEIN; PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN TOLERANT ASTHMA; ASTHMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; BLOOD; CASE CONTROL STUDY; MASS SPECTROMETRY; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; PROTEOMICS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; ASTHMA; ASTHMA, ASPIRIN-INDUCED; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84895927387     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.10.001     Document Type: Article

References (28)

1. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald M., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
2. Bendixen E., Halkier T., Magnusson S., Sottrup-Jensen L., Kristensen T. Complete primary structure of bovine beta 2-glycoprotein I: localization of the disulfide bridges. Biochemistry 1992, 31:3611-3617.
3. Chang H.S., Park J.S., Jang A.S., Park S.W., Uh S.T., Kim Y.H., et al. Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma. Allergy Asthma Immunol Res 2011, 3:256-264.
4. Christiansen S.C., Proud D., Cochrane C.G. Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. JClin Invest 1987, 79:188-197.
5. Dobo J, Major B, Kekesi KA, Szabo I, Megyeri M, Hajela K, et al. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS One 6:e20036.
6. Drouin S.M., Kildsgaard J., Haviland J., Zabner J., Jia H.P., McCray P.B., et al. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. JImmunol 2001, 166:2025-2032.
7. Gerard N.P., Gerard C. Complement in allergy and asthma. Curr Opin Immunol 2002, 14:705-708.
8. Gresele P., Dottorini M., Selli M.L., Iannacci L., Canino S., Todisco T., et al. Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma. JAllergy Clin Immunol 1993, 91:894-902.
9. Kim BS, Park SM, Uhm TG, Kang JH, Park JS, Jang AS, et al. Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 20:748-758.
10. Kowalski M.L., Grzelewska-Rzymowska I., Szmidt M., Rozniecki J., Bednarowicz A. Fibrinolysis, blood coagulation, and platelet function during aspirin-induced bronchoconstriction in aspirin-intolerant asthmatics. Ann Allergy 1987, 58:367-371.
11. Kumlin M., Dahlen B., Bjorck T., Zetterstrom O., Granstrom E., Dahlen S.E. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 1992, 146:96-103.
12. Lee S.H., Rhim T., Choi Y.S., Min J.W., Kim S.H., Cho S.Y., et al. Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 2006, 173:370-378.
13. Marquette C.H., Saulnier F., Leroy O., Wallaert B., Chopin C., Demarcq J.M., et al. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992, 146:76-81.
14. Mascia K., Haselkorn T., Deniz Y.M., Miller D.P., Bleecker E.R., Borish L. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. JAllergy Clin Immunol 2005, 116:970-975.
15. Matsuura E, Shen L, Matsunami Y, Quan N, Makarova M, Geske FJ, et al. Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome. Lupus 19:379-384.
16. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., Swierczynska M., Picado C., Scadding G., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007, 62:1111-1118.
17. Oh SH, Kim YH, Park SM, Cho SH, Park JS, Jang AS, et al. Association analysis of thromboxane a synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 12:351-363.
18. Peng PH, Wu CC, Liu SC, Chang KP, Chen CD, Chang YT, et al. Quantitative plasma proteome analysis reveals aberrant level of blood coagulation-related proteins in nasopharyngeal carcinoma. J Proteomics 74:744-757.
19. Pennings M.T., Derksen R.H., van Lummel M., Adelmeijer J., VanHoorelbeke K., Urbanus R.T., et al. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2'. JThromb Haemost 2007, 5:369-377.
20. Picado C., Castillo J.A., Montserrat J.M., Agusti-Vidal A. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. Eur Respir J 1989, 2:127-129.
21. Pitchford S.C., Riffo-Vasquez Y., Sousa A., Momi S., Gresele P., Spina D., et al. Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 2004, 103:639-647.
22. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
23. Stevenson D.D., Sanchez-Borges M., Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001, 87:177-180.
24. Szczeklik A., Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 2000, 55(Suppl.2):S42-S44.
25. Szczeklik A., Nizankowska E., Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on aspirin-induced asthma. Eur Respir J 2000, 16:432-436.
26. Szczeklik A., Sladek K., Dworski R., Nizankowska E., Soja J., Sheller J., et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996, 154:1608-1614.
27. Wurm H. beta 2-Glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984, 16:511-515.
28. Kim H.S., Kamboh M.I. Genetic polymorphisms of apolipoproteins A-IV, E and H in Koreans. Hum Hered 1998 Nov-Dec, 48(6):313-317.